<H1>Chapter DOI: 10.1208/aapsj070481<br/>Cited-By Count: 49</H1><table border="1" width="30%"><tr><td>Total References</td><td>30</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>30</td></tr><tr><td>BibStructured Count</td><td width="10%">29</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>24</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Butcher SP, Liptrot J, Aburthnott GW. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo microdialysis.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1991;122:245&#8211;248.</td><td><a href=http://dx.doi.org/10.1016/0304-3940(91)90869-U>10.1016/0304-3940(91)90869-U</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Russell V, de Viliers A, Sagvolden T, Lamm M, Taljaard J. Differences between electrically-, Ritalin-, and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired storage of dopamine in an animal model of attention-deficit hyperactivity disorder.<Emphasis Type="Italic">Behav Brain Res</Emphasis>. 1998;94:163&#8211;171.</td><td><a href=http://dx.doi.org/10.1016/S0166-4328(97)00177-0>10.1016/S0166-4328(97)00177-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Horn AS, Coyle JT, Snyder SH. Catecholamine uptake by synaptosomes from rat brain: structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1971;7:66&#8211;80.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Hogan KA, Staal RG, Sonsalla PK. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2000;74:2217&#8211;2220.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2000.0742217.x>10.1046/j.1471-4159.2000.0742217.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Eyerman DJ, Yamamoto BK. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2005;312:160&#8211;169.</td><td><a href=http://dx.doi.org/10.1124/jpet.104.072264>10.1124/jpet.104.072264</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Brown JM, Riddle EL, Sandoval V, et al. A single methamphetamine administration rapidly decreases vesicular dopamine uptake.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;302:497&#8211;501.</td><td><a href=http://dx.doi.org/10.1124/jpet.302.2.497>10.1124/jpet.302.2.497</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2002;449:71&#8211;74.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(02)01985-4>10.1016/S0014-2999(02)01985-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:8705&#8211;8710.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Wayment HK, Deutsch H, Schweri MM, Schenk JO. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1999;72:1266&#8211;1274.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1999.0721266.x>10.1046/j.1471-4159.1999.0721266.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.<Emphasis Type="Italic">Science</Emphasis>. 1987;237:1219&#8211;1223.</td><td><a href=http://dx.doi.org/10.1126/science.2820058>10.1126/science.2820058</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Yeh SY, De Souza EB. Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons.<Emphasis Type="Italic">Drug Alcohol Depend</Emphasis>. 1991;27:51&#8211;61.</td><td><a href=http://dx.doi.org/10.1016/0376-8716(91)90086-E>10.1016/0376-8716(91)90086-E</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Fleckenstein AE, Haughey HM, Metzger RR, et al. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1999;382:45&#8211;49.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(99)00588-9>10.1016/S0014-2999(99)00588-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Daws LC, Callaghan PD, Moron JA, et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;290:1545&#8211;1550.</td><td><a href=http://dx.doi.org/10.1006/bbrc.2002.6384>10.1006/bbrc.2002.6384</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2002;81:292&#8211;300.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2002.00820.x>10.1046/j.1471-4159.2002.00820.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:1181&#8211;1187.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.045005>10.1124/jpet.102.045005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Brown JM, Hanson GR, Fleckenstein AE. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:1150&#8211;1153.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Truong JG, Rau KS, Hanson GR. Fleckenstein. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson&#8217;s neurodegeneration.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003;474: 223&#8211;226.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(03)02080-6>10.1016/S0014-2999(03)02080-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Truong JG, Hanson GR, Fleckenstein AE. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004<Emphasis Type="Italic">a</Emphasis>,492:143&#8211;147.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2004.03.060>10.1016/j.ejphar.2004.03.060</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Truong JG, Newman AH, Hanson GR, Fleckenstein AE. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004<Emphasis Type="Italic">b</Emphasis>;504:27&#8211;32.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2004.09.049>10.1016/j.ejphar.2004.09.049</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Sulzer D, Rayport S. Am phetamine and other psychostimulants reduce pH gradients in midbrain dopamine neurons and chromaffin granules: a mechanism of action.<Emphasis Type="Italic">Neuron</Emphasis>. 1990;5:797&#8211;808.</td><td><a href=http://dx.doi.org/10.1016/0896-6273(90)90339-H>10.1016/0896-6273(90)90339-H</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1995;15:4102&#8211;4108.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Liang NY, Rutledge CO. Evidence for carrier-mediated efflux of dopamine from corpus striatum.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1982;31:2479&#8211;2484.</td><td><a href=http://dx.doi.org/10.1016/0006-2952(82)90057-0>10.1016/0006-2952(82)90057-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Kahlig KM, Binda F, Khoshbouei H, et al. Amphetamine induces dopamine efflux through a dopamine transporter channel.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 2005;102:3495&#8211;3500.</td><td><a href=http://dx.doi.org/10.1073/pnas.0407737102>10.1073/pnas.0407737102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR. A rapid and reversible change in dopamine transporters induced by metham phetamine.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1997;323:R9&#8211;10.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(97)00148-9>10.1016/S0014-2999(97)00148-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Saunders C, Ferrer JV, Shi L, et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine sensitive mechanism.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:6850&#8211;6855.</td><td><a href=http://dx.doi.org/10.1073/pnas.110035297>10.1073/pnas.110035297</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Fleckenstein AE, Gibb JW, Hanson GR. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;406:1&#8211;13.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(00)00639-7>10.1016/S0014-2999(00)00639-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Baucum AJ, Rau KS, Riddle EL, Hansons GR, Fleckenstein AE. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine-and hyperthermia-associated mechanisms.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2004;24:3436&#8211;3443.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.0387-04.2004>10.1523/JNEUROSCI.0387-04.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Baucum</span> <span style='background:#DDDDDD'>AJ</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Cook</span> <span style='background:#DDDDDD'>GA</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hanson</span> <span style='background:#DDDDDD'>JE</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hanson</span> <span style='background:#DDDDDD'>GR</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fleckenstein</span> <span style='background:#DDDDDD'>AE</span></span></aug>. <span style='background:#FFD9B3'>Reactive oxygen species contribute to dopamine transporter oligomerization [abstract]</span>. <i>Exp Biol</i>. 2005; Abstract 312.6.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Cubells JF, Rayport S, Rajendran G, Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1994;14:2260&#8211;2271.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Marek GJ, Vosmer G, Seiden LS. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.<Emphasis Type="Italic">Brain Res</Emphasis>. 1990;517:274&#8211;279.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(90)90467-P>10.1016/0006-8993(90)90467-P</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>